Shalby Partners with Monogram Technologies for Robotic Knee Replacement Clinical Trial

Shalby Limited, a leading multispecialty hospital chain in India, has announced a strategic partnership with Monogram Technologies Inc., a pioneer in AI-driven orthopaedic surgery robotics. The collaboration will focus on conducting a multicenter clinical trial in India to evaluate the safety and effectiveness of Monogram’s mBȏs TKA System, a precision robotic surgical system designed for knee replacements.

Monogram’s mBȏs system is equipped with AI-powered navigation capabilities, enabling it to execute optimised surgical paths for high-precision implant placement autonomously. The goal is to deliver well-balanced, better-fitting knee replacements with minimal bone loss. The company intends to expand its product portfolio to include robotic surgical equipment, software, orthopaedic implants, and other instrumentation for reconstructive joint replacement procedures.

Through this partnership, Shalby will provide access to its network of experienced knee replacement surgeons, led by Dr. Vikram Shah, to evaluate the mBȏs TKA System with the Consensus CKS implant. Monogram will use the clinical trial data to support international regulatory approvals and commercialisation efforts.

Both companies believe that the mBȏs system has the potential to revolutionise knee replacement surgery by offering a highly intuitive, safe, and accurate robotic platform. The partnership is expected to evolve, with future collaborations exploring additional applications and technologies, such as Monogram’s mVision navigation system.

“As the largest orthopaedic hospital group in the world, we have the privilege with our esteemed surgeons of evaluating the leading robots and advanced technologies on the market, including pipeline products”, said Dr. Vikram Shah, Chairman of Shalby Limited.

He further added, “We have seen the mBȏs TKA System and next-gen pipeline firsthand and can say definitively that what they are working on will change the face of orthopaedic medicine forever. We are excited to partner with Monogram and believe the market potential in the United States and globally for their system is very significant and could scale very quickly. We look forward to working with the Monogram team and broadening our relationship over the months to come.”

“With over 200,000 TKAs annually, India represents a massive market potential driven by a large population and demographic tailwinds. India is underpenetrated for robotics but rapidly growing, and we believe the market potential is likely in the hundreds of systems,” said Ben Sexson, CEO of Monogram Technologies Inc.

He further added, “Shalby is a world-class organisation, and we have been nothing but impressed by the calibre of their surgeons and standard of care. We resonate with Shalby’s ambitions and growth plans globally, including in the United States and look forward to validating the value proposition of the mBȏs TKA System with real-world data. Our recent 510(k) submission is a catalyst for strategic synergies.”

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.